BDBM237366 US10052306, 182::rac-(3aR,5R,6aS)-2-[2- hydroxy-2-(4- hydroxyphenyl)ethyl]-5- [(4- methylphenyl)methyl]- octahydrocyclopenta[c] pyrrol-5-ol

SMILES Cc1ccc(C[C@@]2(O)C[C@@H]3CN(CC(O)c4ccc(O)cc4)C[C@@H]3C2)cc1

InChI Key InChIKey=GRVIMMFNLGKLBH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237366   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM237366(rac-(3aR,5R,6aS)-2-[2- hydroxy-2-(4- hydroxyphenyl...)
Affinity DataIC50: 41.5nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent